Table 3.
Patient characteristics and treatment outcomes (High-risk patients).
| RT-group | CCRT-group | P-value | |||
|---|---|---|---|---|---|
| Patient characteristics | Number of patients | 34 | 34 | ||
| Age (mean) | 51.3 | 50.1 | |||
| Clinical stage | IA2 | 0 | 0 | ||
| IB | 7 | 12 | |||
| IIA | 9 | 2 | |||
| IIB | 18 | 20 | |||
| Histology | Squamous cell | 21 | 25 | ||
| Adenocarcinoma | 13 | 8 | |||
| Adenosquamous | 0 | 1 | |||
| Others | 0 | 0 | |||
|
| |||||
| Treatment outcome | Duration of radiotherapy | Days | 38 | 38 | NS |
| Patients with recurrence (%) | 16 (47.0) | 9 (26.5) | NS | ||
| PFS (months) | Mean | 22.6 | 29.5 | NS | |
| OS (months) | Mean | 29.7 | 34.2 | .0364 | |
PFS: progression-free survival, OS: overall survival, CCRT: concurrent chemoradiotherapy, RT: radiotherapy.